Physicians at Connecticut GI are involved in state of the art research that targets conditions of the upper and lower GI tract. Studies are conducted in our offices and at our Endoscopy Centers, and include new medications, procedures, and therapeutic devices. Our experienced research team includes gastroenterologists, nurse practitioners, physician assistants, nurses, medical assistants, and research coordinators. Our goal is to provide access to research protocols so that our patients will benefit from the newest therapies.

Connecticut GI Research Division is focused on improving the quality of our patient’s health. Our mission is to provide superior cutting-edge clinical trials to make advancements in new cures. Every research study supports patient care and patient needs. Our dedicated and experienced research staff conduct clinical trials with compassion and respect for participants.

We offer our patients the opportunity to participate in clinical trials for the following:

Eosinophilic Esophagitis

Does the thought of eating certain foods make you anxious or uneasy? Do they trigger swallowing difficulties, vomiting, or abdominal pain? Then you may be able to take part in a new clinical study.

Usually, your immune system does a great job of keeping you healthy. But sometimes, it reacts to things it shouldn’t – like food. Eosinophilic esophagitis (EoE) is thought to be a type of allergy that is often caused by food or things that you inhale in the environment. When someone with EoE eats certain foods or breathes in certain substances, a type of white blood cell called eosinophils collects in their esophagus (the tube that connects the mouth to the stomach). These eosinophils aren’t normally found in the esophagus and can cause symptoms such as abdominal pain, swallowing difficulties or vomiting.

To date, no medications have been approved to treat this condition. So our study team is looking for people with EoE to join a clinical research study.

To learn more about this clinical trial titled “Orbit 1”, please visit: www.OrbitEoE.com.

Please contact our office at 860-409-4567 x108 if you are interested.

Gerd Or Reflux

BARRETT’S ESOPHAGUS: (WATs 3D BRUSH BIOPSY STUDY):

A breakthrough endoscopy procedure can help your doctor to detect early-stage, pre-cancerous cells (also known as Barrett’s Esophagus) so they can be removed long before they can turn into esophageal cancer.

By recording the results of all of your biopsies over many years, it may be possible to find out if the brush biopsy, forceps biopsy, or both can predict which patients with heartburn develop Barrett’s esophagus, (an abnormality in the esophagus that may lead to cancer), and which patients with Barrett’s esophagus develop pre-cancer and cancer. The data from your biopsies will be used to determine the best way to diagnose esophageal disease.

To learn more about this registry study, please visit: www.wats3dforme.com

Please contact our office at 860-409-4567 x108 if you are interested.

Crohn's Disease

Are you living with Crohn’s disease?
Do you still have symptoms after receiving treatment?

We are looking for volunteers to help us evaluate the safety and effectiveness of a potential new treatment option for patients with Crohn’s.

You may be able to take part if you:

  • are 18 years of age or older
  • have been diagnosed with Crohn’s for at least 3 months
  • have active Crohn’s that did not improve or stay improved after trying at least one Crohn’s therapy

The REVOLVE Study may last for up to 15 months and will require visits to the study center every 4 weeks. You will be monitored carefully by a team of doctors and study coordinators. All study-related medications and assessments will be provided at no cost to you.

Please contact our office at 860-409-4567 x108 if you are interested.